Report Generated by IMBA Professional Plus Academic Edition on 6/29/2007 Report Filename is Z:\USERS\Stacey\USTUR_COP_Website_ACJ\IPP Article\USTUR_0855 - 241AmO2.RPT *************************************************************** ADMINISTRATIVE DETAILS ********************** NAME: Anonymous Date of Birth: Employee ID: Employee SSN: Sex: Male Case ID: USTUR Case 0855 File Name Prefix: Case Flag: Description of Case: Special Bioassay Study Date of Assessment: Additional Comments: Living (Healthy) USTUR Registrant Single Acute Inhalation of 241AmO2 in 1996 6-y Follw-up Study - Published in Health Phys. SOFTWARE VERSION **************** IMBA Professional Plus Academic Edition Issued in May 2006 Version number 4.0.42 INDICATOR RADIONUCLIDE ********************** Radionuclide: Halflife: 0 (d) ASSOCIATED RADIONUCLIDES ************************ There are no radionuclides associated with the indicator radionuclide. INTAKE REGIMES ************** There is only one intake regime Intake 1 :acute inhalation on day 0 MODEL PARAMETERS **************** The following model parameters apply to all intake regimes MEASUREMENT DATA **************** During the fitting procedure, the following data were used: RADIATION WEIGHTING FACTORS *************************** Not Specified ALPHA: 0 BETA: 0 GAMMA: 0 TISSUE WEIGHTING FACTORS ************************ Not Specified Splitting rule applied to highest named organ Remainder organs selected from the following list: INTAKES ******* Intake 1 was 0 Bq BIOASSAY RESULTS **************** EQUIVALENT DOSES (Indicator Nuclide) in Sv ****************************************************** ORGAN, Equivalent dose to organ from each intake regime (Sv) , IR(1) , TOTAL Adrenals, 0.00E+00, 0.00E+00 Urinary Bl, 0.00E+00, 0.00E+00 Brain, 0.00E+00, 0.00E+00 Breast, 0.00E+00, 0.00E+00 Gall Bladd, 0.00E+00, 0.00E+00 Heart Wall, 0.00E+00, 0.00E+00 Kidneys, 0.00E+00, 0.00E+00 Liver, 0.00E+00, 0.00E+00 Muscle, 0.00E+00, 0.00E+00 Ovaries, 0.00E+00, 0.00E+00 Pancreas, 0.00E+00, 0.00E+00 Testes, 0.00E+00, 0.00E+00 Thyroid, 0.00E+00, 0.00E+00 R.B.M., 0.00E+00, 0.00E+00 Bone Surfa, 0.00E+00, 0.00E+00 Stomach, 0.00E+00, 0.00E+00 S.I., 0.00E+00, 0.00E+00 U.L.I., 0.00E+00, 0.00E+00 L.L.I., 0.00E+00, 0.00E+00 Skin, 0.00E+00, 0.00E+00 Spleen, 0.00E+00, 0.00E+00 Thymus, 0.00E+00, 0.00E+00 Uterus, 0.00E+00, 0.00E+00 ET, 0.00E+00, 0.00E+00 Lung, 0.00E+00, 0.00E+00 Colon, 0.00E+00, 0.00E+00 ET1, 0.00E+00, 0.00E+00 ET2, 0.00E+00, 0.00E+00 LN(ET), 0.00E+00, 0.00E+00 BBsec, 0.00E+00, 0.00E+00 BBbas, 0.00E+00, 0.00E+00 bb, 0.00E+00, 0.00E+00 AI, 0.00E+00, 0.00E+00 LN(TH), 0.00E+00, 0.00E+00 Esophagus, 0.00E+00, 0.00E+00 Gonads, 0.00E+00, 0.00E+00 Spare, 0.00E+00, 0.00E+00 Remainder, 0.00E+00, 0.00E+00 Note: total equivalent dose to remainder is not derived by adding the dose to remainder from each intake regime. Note(A): The additional energy from the nucleus caused by alpha recoil will have been included if necessary Note(B): These calculations have been optimised for accuracy EFFECTIVE DOSE (Indicator Nuclide) in Sv ********************************************* ORGAN, Contribution to effective dose from each intake regime (Sv) , IR(1) , Total Contribution Adrenals, 0.00E+00, 0.00E+00 Urinary Bl, 0.00E+00, 0.00E+00 Brain, 0.00E+00, 0.00E+00 Breast, 0.00E+00, 0.00E+00 Gall Bladd, 0.00E+00, 0.00E+00 Heart Wall, 0.00E+00, 0.00E+00 Kidneys, 0.00E+00, 0.00E+00 Liver, 0.00E+00, 0.00E+00 Muscle, 0.00E+00, 0.00E+00 Ovaries, 0.00E+00, 0.00E+00 Pancreas, 0.00E+00, 0.00E+00 Testes, 0.00E+00, 0.00E+00 Thyroid, 0.00E+00, 0.00E+00 R.B.M., 0.00E+00, 0.00E+00 Bone Surfa, 0.00E+00, 0.00E+00 Stomach, 0.00E+00, 0.00E+00 S.I., 0.00E+00, 0.00E+00 U.L.I., 0.00E+00, 0.00E+00 L.L.I., 0.00E+00, 0.00E+00 Skin, 0.00E+00, 0.00E+00 Spleen, 0.00E+00, 0.00E+00 Thymus, 0.00E+00, 0.00E+00 Uterus, 0.00E+00, 0.00E+00 ET, 0.00E+00, 0.00E+00 Lung, 0.00E+00, 0.00E+00 Colon, 0.00E+00, 0.00E+00 ET1, 0.00E+00, 0.00E+00 ET2, 0.00E+00, 0.00E+00 LN(ET), 0.00E+00, 0.00E+00 BBsec, 0.00E+00, 0.00E+00 BBbas, 0.00E+00, 0.00E+00 bb, 0.00E+00, 0.00E+00 AI, 0.00E+00, 0.00E+00 LN(TH), 0.00E+00, 0.00E+00 Esophagus, 0.00E+00, 0.00E+00 Gonads, 0.00E+00, 0.00E+00 Spare, 0.00E+00, 0.00E+00 Remainder, 0.00E+00, 0.00E+00 TOTAL, 0.00E+00, 0.00E+00 Note: total equivalent dose to remainder is not derived by adding the dose to remainder from each intake regime. LOGIC used in calculating effective doses: Note(A): The additional energy from the nucleus caused by alpha recoil will have been included if necessary Note(B): These calculations have been optimised for accuracy ANNUAL COMMITTED EFFECTIVE DOSES in Sv ******************************************************************************************** Annual doses (inc. total) calculated for Indicator nuclide only year, (n/a)*, Effective Dose Total, Note(A): The additional energy from the nucleus caused by alpha recoil has been included where necessary Note(B): These calculations have been optimised for accuracy * Indicator radionuclide